Leptin and adiponectin have been shown to have contrary functions on breast cancer progression, leptin displaying tumor-promoting and adiponectin tumor-suppressive roles, f.i. through cell proliferation (Vona-Davis and Rose, 2007; Yan et al., 2012; Kato et al., 2015). Here, ADIPOQ is linked to breast carcinoma.